Loading clinical trials...
Loading clinical trials...
A Feasibility Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System
Conditions
Interventions
ExAblate Transcranial System
Locations
5
United States
Stanford University Medical Center
Stanford, California, United States
University of Maryland Medical System
Baltimore, Maryland, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
The Ohio State Wexner Medical Center
Columbus, Ohio, United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
April 1, 2015
Primary Completion Date
May 15, 2019
Completion Date
July 26, 2019
Last Updated
January 19, 2022
NCT07330258
NCT06508801
NCT07310264
NCT02119611
NCT07216976
NCT06402955
Lead Sponsor
InSightec
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions